Authors : Reza Mirzaeiebrahimabadi; Afsaneh Taghizadehghasemabadi; Saber Bakhtiaryfar; Mohsen Dadras Jedi Pishkhani; MohammadrezaBaloochirezaei; Mobinaalsadat Taghavi

Volume/Issue : Volume 9 - 2024, Issue 9 - September

Google Scholar : https://tinyurl.com/5e3rytfj

Scribd : https://tinyurl.com/5effdsp3

DOI : https://doi.org/10.38124/ijisrt/IJISRT24SEP767

Abstract : Alzheimer’s disease (AD) and Parkinson’s disease (PD) are examples of Neurodegenerative diseases (NDs) that are clinically described by progressive neuronal dysfunction and structural disintegration culminating in significant cognitive and motor dysfunction. These conditions can be classified as a significant concern of public health because they are seen more often and impose a rather heavy load on patients and the healthcare system. In this scenario, various research done in the recent past has revealed a probability of a connection between oral hygiene, specifically periodontal disorder, and the development of these diseases. This integrated literature review seeks to analyze periodontal disease, changes in oral flora, and the occurrence of neurodegenerative diseases (NDs). Possible pathological factors, such as chronic inflammation, bacterial penetration, amyloidogenic cascade, and oxidative mechanisms are described, as well as the effectiveness of oral hygiene measures on the outcomes of the disease. Moreover, we also investigate the functionality of periodontal treatments, enhanced oral hygiene practices, and antimicrobial treatments as measures that help to reduce these impacts. Such associations could helpto reveal new possibilities for the prevention and treatment of NDs based on a multimodal approach. The present review sums up the existing literature,discusses the gaps in knowledge, and suggests the further directions for clinical practice and research stressing the necessity of a multimodal approach to enhance patient outcomes.

Keywords : Oral Health, Neurodegenerative Diseases, Periodontal Disease, Alzheimer's Disease, Parkinson's Disease.

References :

1. Hardy, J., & Selkoe, D. J. (2002). The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science (New York, N.Y.), 297(5580), 353–356. https://doi.org/10.1126/science.1072994
2. Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D., & Jones, E. (2011). Alzheimer's disease. Lancet (London, England), 377(9770),               1019–1031. https://doi.org/10.1016/S0140-6736(10)61349- 9
3. Chen, C. K., Wu, Y. T., & Chang, Y. C. (2017). Periodontal inflammatory disease is associated with the risk of Parkinson's disease: a population-based retrospective matched-cohort study. PeerJ, 5,  e3647. https://doi.org/10.7717/peerj.3647.
4. Pihlstrom, B. L., Michalowicz, B. S., & Johnson, N. W.   (2005).   Periodontal diseases. Lancet (London, England), 366(9499), 1809–1820. https://doi.org/10.1016/S0140-6736(05)67728- 8.
5. Holmer, J., Eriksdotter, M., Schultzberg, M., Pussinen, P. J., & Buhlin, K. (2018). Association between periodontitis and risk of Alzheimer's disease, mild cognitive impairment and subjective cognitive decline: A case-control study. Journal of clinical periodontology, 45(11), 1287–1298. https://doi.org/10.1111/jcpe.13016
6. D'Aiuto, F., Parkar, M., Andreou, G., Suvan, J., Brett, P. M., Ready, D., & Tonetti, M. S. (2004). Periodontitis and systemic inflammation: control of the local infection is associated with a reduction    in    serum     inflammatory markers. Journal of dental research, 83(2), 156–160. https://doi.org/10.1177/154405910408300214.
7. Dominy, S. S., Lynch, C., Ermini, F., Benedyk, M., Marczyk, A., Konradi, A., Nguyen, M., Haditsch, U., Raha, D., Griffin, C., Holsinger, L. J., Arastu-Kapur, S., Kaba, S., Lee, A., Ryder, M. I., Potempa, B., Mydel, P., Hellvard, A., Adamowicz, K., Hasturk, H.,… Potempa, J. (2019). Porphyromonas gingivalis in Alzheimer's disease brains: Evidence for disease causation and treatment with small-molecule        inhibitors. Science advances, 5(1), eaau3333. https://doi.org/10.1126/sciadv.aau3333
8. Pritchard, A. B., Crean, S., Olsen, I., & Singhrao, S. K. (2017). Periodontitis, Microbiomes and their Role in Alzheimer's Disease. Frontiers in aging neuroscience, 9, 336. https://doi.org/10.3389/fnagi.2017.00336
9. Rogers, G. B., Keating, D. J., Young, R. L., Wong, M. L., Licinio, J., & Wesselingh, S. (2016). From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways. Molecular psychiatry, 21(6), 738–748. https://doi.org/10.1038/mp.2016.50
10. Kamer, A. R., Craig, R. G., Dasanayake, A. P., Brys, M., Glodzik-Sobanska, L., & de Leon, M. J. (2008). Inflammation and Alzheimer's disease: possible role   of   periodontal diseases. Alzheimer's & dementia: the journal of the Alzheimer's Association, 4(4), 242–250. https://doi.org/10.1016/j.jalz.2007.08.004
11. Perry, V. H., Nicoll, J. A., & Holmes, C. (2010). Microglia in neurodegenerative disease. Nature reviews. Neurology, 6(4), 193–201. https://doi.org/10.1038/nrneurol.2010.17
12. Poole, S., Singhrao, S. K., Kesavalu, L., Curtis, M. A., & Crean, S. (2013). Determining the presence of periodontopathic virulence factors in short-term postmortem Alzheimer's disease brain tissue. Journal of Alzheimer's disease : JAD, 36(4), 665–677. https://doi.org/10.3233/JAD-121918
13. Ide, M., Harris, M., Stevens, A., Sussams, R., Hopkins, V., Culliford, D., Fuller, J., Ibbett, P., Raybould, R., Thomas, R., Puenter, U., Teeling, J., Perry, V. H., & Holmes, C. (2016). Periodontitis and Cognitive Decline in Alzheimer's Disease. PloS one, 11(3), e0151081. https://doi.org/10.1371/journal.pone.0151081
14. Noble, J. M., Borrell, L. N., Papapanou, P. N., Elkind, M. S., Scarmeas, N., & Wright, C. B. (2009). Periodontitis is associated with cognitive impairment among older adults: analysis of NHANES-III. Journal of neurology, neurosurgery, and psychiatry, 80(11), 1206–1211. https://doi.org/10.1136/jnnp.2009.174029
15. Watts, A., Crimmins, E. M., & Gatz, M. (2008). Inflammation as a potential mediator for the association between periodontal disease and Alzheimer's disease. Neuropsychiatric disease and treatment, 4(5), 865–876. https://doi.org/10.2147/ndt.s3610